Mark S. Gelder MD - 14 Jun 2021 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role
Chief Medical Officer
Signature
/s/ Mark Guerin as attorney-in-fact
Issuer symbol
TRAW
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 19:46:07 UTC
Next filing
04 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Stock Option (right to purchase) Award $0 +20,000 $0.000000 20,000 14 Jun 2021 Common Stock 20,000 $7.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Theses options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years.